Using a bovine 61-kDa (PDE1A2) calmodulin-stimulated phosphodiesterase (CaM-PDE) cDNA and a bovine lung 59-kDa (PDE1A1) CaM-PDE cDNA reported here, we have identified two new regions within the primary structure of these two related isozymes that are important for regulation by Ca 2؉ /CaM. PDE1A1 is identical to the PDE1A2 isozyme except for the amino-terminal 18 residues. In agreement with earlier studies, the CaM concentration required for half-maximal activation (K CaM ) of recombinant PDE1A1 (0.3 nM) was Ϸ10-fold less than the K CaM for recombinant PDE1A2 (4 nM). A series of deletion mutations of the PDE1A2 cDNA removing nucleotide sequence encoding the first 46 -106 aminoterminal residues were constructed and expressed using the baculovirus system. Deletion of the amino acids encompassing a previously identified, putative CaMbinding domain (residues 4 -46) produced a polypeptide that was still activated 3-fold by CaM (K CaM Ϸ 3 nM). However, complete CaM-independent activation occurred when residues 4 -98 were deleted. To determine the location of the additional CaM-binding domain(s), the inhibitory potency of seven overlapping, synthetic peptides spanning amino acids 76 -149 of PDE1A2 was tested using the CaM-activated enzyme. One peptide spanning amino acids 114 -137 of PDE1A2 appeared to be the most potent inhibitor of CaM-stimulated activity. These results reveal the existence of a CaM-binding domain located approximately 90 residues carboxyl-terminal to the putative CaM-binding domains previously identified within the PDE1A1 and PDE1A2 isozymes. Moreover, a discrete segment important for holding these CaM-PDEs in a less active state at low Ca 2؉ concentrations is located between the two CaM-binding domains.Calmodulin-stimulated cyclic nucleotide phosphodiesterases (CaM-PDEs) 1 constitute a genetically diverse class of cAMP and cGMP hydrolyzing activities that are activated by calcium and calmodulin (1). Several different CaM-PDE activities have been identified (2). These CaM-PDE isozymes are distributed among discrete cell types in various tissues and have varying substrate specificity, specific activities, and activation constants (K CaM ) for CaM (2, 3). In cells that express CaM-PDEs, hormones that increase cytosolic Ca 2ϩ would be predicted to activate this isozyme, thereby decreasing cyclic nucleotide accumulation in response to hormones that stimulate cAMP or cGMP synthesis.In addition to Ca 2ϩ /CaM, certain CaM-PDEs may be subject to a secondary form of regulation via phosphorylation. In vitro, the 59-kDa (PDE1A1) and 61-kDa (PDE1A2) CaM-PDEs 2 are phosphorylated by cAMP-dependent protein kinase (4, 5), while the autophosphorylated form of CaM-dependent protein kinase II catalyzes the phosphorylation of the 63-kDa (PDE1B1) CaM-PDE (6). Phosphorylation increases the K CaM , effectively rendering these isozymes less sensitive to activation by Ca 2ϩ (7,8). In vivo, CaM-PDE phosphorylation would likely result in potentiation of cAMP or cGMP accumulation in response to hormonal stimuli involving coin...